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Abstract
Background: Euvolemia is an important adequacy parameter in peritoneal dialysis (PD) patients. However, accurate tools to
evaluate volume status in clinical practice and data on volume status in PD patients as compared to healthy population, and
the associated factors, have not been available so far.
Methods:We used a bio-impedance spectroscopy device, the Body Composition Monitor (BCM) to assess volume status in a
cross-sectional cohort of prevalent PD patients in different European countries. The results were compared to an age and
gender matched healthy population.
Results: Only 40% out of 639 patients from 28 centres in 6 countries were normovolemic. Severe fluid overload was present
in 25.2%. There was a wide scatter in the relation between blood pressure and volume status. In a multivariate analysis in
the subgroup of patients from countries with unrestricted availability of all PD modalities and fluid types, older age, male
gender, lower serum albumin, lower BMI, diabetes, higher systolic blood pressure, and use of at least one exchange per day
with the highest hypertonic glucose were associated with higher relative tissue hydration. Neither urinary output nor
ultrafiltration, PD fluid type or PD modality were retained in the model (total R2 of the model = 0.57).
Conclusions: The EuroBCM study demonstrates some interesting issues regarding volume status in PD. As in HD patients,
hypervolemia is a frequent condition in PD patients and blood pressure can be a misleading clinical tool to evaluate volume
status. To monitor fluid balance, not only fluid output but also dietary input should be considered. Close monitoring of
volume status, a correct dialysis prescription adapted to the needs of the patient and dietary measures seem to be
warranted to avoid hypervolemia.
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Introduction
Euvolemia is a predictor of outcome in peritoneal dialysis (PD)
patients, as [1,2]volume overload is related to cardiac dysfunction
[3,4,5], inflammation [6] and mortality [7]. Euvolemia is probably
a more important adequacy parameter than small solute
clearance, as fluid status [7] but not small solute clearance [8]
predicts outcome. Guidance on how to achieve and maintain
euvolemia in individual PD patients is hampered by the absence of
a convenient device to measure volume status, and by the lack of
insight in the prevalence of and factors associated with volume
overload.
In clinical practice, the assessment of volume status is relatively
crude. Volume status is often assessed indirectly by measuring fluid
removal, failing to take into account fluid balance by omission of
dietary fluid intake. Ultrasonic evaluation of inferior vena cava
diameter (IVC) only assesses intravascular volume, and is also
influenced by diastolic dysfunction [9] [10], and is thus a reflection
of preload, and not of tissue hydration[11]. Parameters, such
as Brain Natriuretic Peptide (BNP) or NT-proBNP can reflect
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changes in hydration status [12], but are also influenced both by
preload and ventricular abnormalities, and in patients with renal
failure, accumulation can occur [13]. Direct measurement of
extracellular (ECW) and total body water (TBW) by dilution
methods is considered as the golden standard, but these techniques
are laborious and expensive [14].
Bio-impedance spectroscopy (BIS) represents a different ap-
proach to the assessment of fluid status [11,15,16]. By measuring
the flow of electrical current through the body, resistance and
reactance can be measured, and in BIS, this is performed at
different frequencies [17]. The Body Composition Monitor (BCM,
Fresenius Medical Care, Germany) is a bio-impedance spectros-
copy device for clinical use, validated by isotope dilution methods
[18], and reference body composition methods [19], and has been
used in hemodialysis (HD) [20,21,22,23] and PD [24].
The fluid status in PD patients has so far not been characterized
by a method that allows comparison to the normal healthy
populations. Some studies have evaluated the volume status of PD
patients in relation to modality (APD vs. CAPD) [25,26] transport
status, residual renal function [27], or inflammation [28].
However, whereas these studies contribute information on relative
volume status in different groups of PD, they were hampered to
express the degree of true fluid overload due to the lack of a
reference population. In contrast, Wieskotten et al [29] evaluated a
large cohort of 688 healthy persons using the BCM to derive
reference ranges, allowing to compare fluid overload as measured
by BCM to age and gender matched values of the normal healthy
population. In addition, expressing extracellular and intracellular
water as absolute values induces the problem of scaling to body
size. In previous studies using bio-impedance, ratios of extracel-
lular water to height, weight, body surface area, intracellular water
or total body water [30] have been used to express ‘‘fluid
overload’’, but the ideal scaling parameter remains a matter of
debate [14]. The use of relative Dtissue hydrationdiminishes the
problem of scaling nearly completely, and allows comparison to
the healthy population [29]. In HD patients [20] relative Dtissue
hydration is associated with mortality, indicating the clinical
relevance of this parameter.
The European Body Composition study (EuroBCM study)
in PD was designed to measure hydration status in a large,
multicentric cohort of PD patients using the BCM device,
as compared to a healthy reference population, and to establish
associations between clinical and practice related parameters and
volume status.
Methods
Study objectives
The EuroBCM study in PD was a cross sectional, observational,
multi center trial in 28 centers in 6 European countries. The
primary objective was to analyze hydration status in a represen-
tative sample of prevalent PD patients as compared to the healthy
population, and to identify associations between hydration status
and patient characteristics (age, gender, diabetes, peritoneal
transport characteristics, residual renal function, and daily
ultrafiltration) and treatment practice (type of PD solution, use
of APD vs CAPD) to find out which conditions should alert the
clinician to potential fluid overload.
Centers
Patients were recruited from 6 different European countries
(Belgium, France, Poland, Romania, United Kingdom, and
Switzerland). Centers were selected to reflect the distribution of
PD in that country, aiming to an overall inclusion of 610% of the
total number of PD patients of that country.
Patients
In each center, all prevalent patients on PD were assessed for
eligibility for inclusion (prevalent cross-sectional cohort approach)
if they were older than 18 years of age and wanted to sign
informed consent. Patients were excluded if they had a cardiac
pacemaker or metallic implants, were amputees or were pregnant.
Patients were evaluated during a routine clinical visit. All patients
signed informed consent, and ethical advice was obtained from
the individual ethics committees as per country protocol.
This trial has been registered at the Cochrane Renal Group
trials registry (http://www.cochrane-renal.org) under the number
CRG110800153.
Measurements of hydration and body composition
BCM measurements were in each center performed by one
reference PD physician or nurse, using a portable whole body bio-
impedance spectroscopy device, the BCM (Fresenius Medical
Care). The BCM measures the impedance spectroscopy at 50
different frequencies between 5 kHz and 1 MHz. The BCM was
validated intensively against all available gold-standard methods
[19]. Clinically relevant parameters were registered in the case
report form (CRF).
Electrodes were attached to one hand and one foot at the
ipsilateral side, after the patient had been in recumbent position
for at least 5 minutes. Due to bio-physical reasons, bio-impedance
spectroscopy does not measure sequestered fluid in the trunk
[25,31,32,33]. Therefore, presence or absence of PD fluid in the
abdomen does not influence the readings of hydration status. For
determination of weight, we used the weight adjusted for empty
abdomen.
Extracellular water (ECW), intracellular water (ICW) and total
body water (TBW) were determined from the measured
impedance data following the model of Moissl et al [18].
Reproducibility of BCM derived parameters is high, with a
coefficient of variation for the interobserver variability ECW and
TBW around 1.2% [34]. Therefore, only one BCM measurement
was performed in each individual patient.
Absolute DTissue Hydration (ADTH) was derived from the
impedance data based on a physiologic tissue model [35,36].
Absolute DTissue Hydration represents the difference between the
amount of ECW in the tissue as actually detected by the BCM and
the amount of water present in tissue, as predicted by physiological
models under normal physiological (normohydrated) conditions
[36]. Of note, ADTH has no direct relation to circulating volume.
All values of ADTH were compared with and categorized
according to the 10th (corresponding to 21.1l) and 90th
(corresponding to +1.1l) percentiles of a population of the same
gender distribution and with a comparable age band out of a
healthy reference cohort, where hydration status was measured
with the identical technology [29,37].
ADTH is further normalized to extracellular water, and
expressed as a ratio called Relative DTissue Hydration (RDTH
= ADTH/ECW). In the normal reference population, the 90th
percentile of RDTH is 7%. Accordingly, when RDTH was greater
than 7%, this was classified as ‘‘fluid overload’’. As a RDTH ratio
.15% is related to mortality [20], this cut off was used to define
‘‘severe fluid overload’’.
Blood pressure was recorded as the mean of two consecutive
measurements with 5 minutes interval, using one single calibrated
device in each center. Height and weight were measured using one
single calibrated device in each center.
Fluid Status in PD by BCM
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Patient characteristics
Diabetes was assumed to be present in patients using glucose
lowering drugs or insulin.
Congestive heart failure was defined according to the New York
Heart Association (NYHA) classification. Ultrafiltration was calcu-
lated from the patient’s charts as a daily mean of ultrafiltration (in ml)
obtained during the last month preceding the measurement. Due to
the daily variation, residual diuresis was assessed in a categorical way
(,100 ml, between 100 and 500 ml/day, between 500 and
1000 ml/day, or .1000 ml/day) based on the reported current
urine production. Total fluid output was estimated as the sum of
urinary, taken as the halfway value of the cohort, and ultrafiltered
volume per 24 hour. In this way, a patient with zero ultrafiltration
and a reported urinary output in the 500–1000 ml/day has a total
output of 750 ml, the cut off value in the EAPOS study [38].
The following biochemical parameters were determined in the
local laboratories from blood collected during the routine visit:
hemoglobin, hematocrit, albumin, CRP, urea, creatinine.
Peritoneal membrane characteristics were determined based on
results of the last available PET test preceding the BCM measurement,
according to Twardowski [39]. If no PET test was available the last
four months, transport status was noted as ‘‘unknown’’
Statistical analysis
Continuous data are expressed as mean 6 standard deviation.
Categorical variables are expressed as percentage of total. For
univariate comparisons, student’s t-test, Mann Whitney U-test and
Fisher’s exact test were used. One-way ANOVA was used to
compare multiple categories, with post hoc testing.
Multivariate linear regression analysis was performed with
relative Dtissue hydration as the target variable, to find factors
which were independenly associated with overhydration, and
should thus alert the physician for this condition. Switzerland was
excluded from the multivariate analysis as the low patient number
made the models unstable. Since the implementation of APD and
polyglucose was very low in Romania and Poland, it was decided
to analyse only patients from UK, Belgium and France in the
multivariate analysis.
Variables were selected for entry in the model selection
procedure either because of univariate p,0.1 or for biological
plausibility. Regression diagnostics was performed to detect and
eliminate outliers and highly influential observations.
All analyses were done with SAS V9.2 (SAS Institute inc, Cary,
North Carolina).
Results
Of the prevalent patients in the study centers, 734 were eligible
for the study, 73 of whom were excluded because of predefined
contra-indications for BCM measurement: metal implants or
artificial joints: n = 48, pacemakers or implanted pumps: n = 15,
amputations: n = 10. From the remaining 661 patients, 22 patients
had incomplete data.
Patients were recruited from Belgium (5 centers, n = 98), France
(5 centers, n = 65), Poland (5 centers, n = 82), Romania (9 centers,
n = 218), United Kingdom (2 centers, n = 167) and Switzerland
(1 center, n = 9).
The baseline demographic, clinical, relevant laboratory data
and hydration parameters of the population are provided in
table 1. In this population, 24.4% were diabetic, and 32.1% had
signs of heart failure (9.7, 12.2, 8.1 and 2.0% NYHA class 1, 2, 3
or 4 respectively). Some patients had previously been treated by
HD (18.3%), or had a failed transplant (4.9%). Average time on
PD was 32.6631.0 months. At least one type of antihypertensive
drug was taken by 85.4% of the patients (44.9% diuretics, 46.8%
Beta blocking agents, 41.5% calcium antagonists, 51.2% inhibitors
of the renin- angiotensin system, 9% central acting drugs).
Underhydration (ADTH,10th percentile), normohydration and
overhydration (ADTH.90th percentile), as defined by the 10th and
90th percentile of values obtained in the normal population [29],
were present in 6.7, 39.9 and 53.4% of the EuroBCM cohort.
Fluid overload and severe fluid overload, as defined by a relative
Dtissue hydration (ADTH/ECW) above 7% or above 15% were
present in 53.4 and 25.2% of the study population.
Univariate analysis
There was a substantial scatter on the linear relationship
between ADTH and systolic blood pressure, diastolic blood
pressure or pulse pressure (correlation coefficients 0.23, 0.02 and
0.29 respectively). As described elsewhere for HD patients [22,37],
different zones (figure 1) can be identified in the plot of systolic
blood pressure (Y-axis) versus ADTH (X-axis), of patients who are
both normohydrated and normotensive (26.8%, zone A), who are
both fluid overloaded and hypertensive (25.8%, zone B), who are
hypertensive despite being normo- or underhydrated (13.3%, zone
C), who are normo- and hypotensive despite being fluid
overloaded (27.5%, zone D) and patients who are hypotensive
and normohydrated or normotensive and underhydrated (6.6%,
zone E)
Males (vs females, 2.1962.57 vs 1.0361.82 l, p,0.001) and
diabetics (vs non diabetics, 1.9262.12 vs 1.5262.38 l, p = 0.06)
had a higher ADTH. The prevalence of PD patients with a
ADTH.90th percentile of the normal healthy reference popula-
tion was also higher in males as compared to females (65.0 vs
39.3%). There was no impact of ‘‘vintage on PD’’ on ADTH (time
on PD of patients with an ADTH.1.1 liter vs euvolaemic patients
32.5628.0 vs 33.4634.4 months, p = 0.66).
There was a correlation between transport status and ADTH
(figure 2), with a declining trend from fast (2.0462.75 l) to fast
average (1.6362.34 l), slow average (1.2361.97 l) and slow
(0.7661.71 l) transport status (ANOVA: p,0.001). However the
interquartile range in each group was substantial, and there is
considerable overlap in ADTH between the groups. ADTH was
most increased in those patients where transport status had not
routinely been measured in the last four months (2.4862.42 l,
post-hoc p-value vs. slow transport status p,0.0001). There was a
trend for declining ADTH with increasing urinary output from
,100 ml/day (1.9962.38 l), over 100–500 ml/day (1.8462.77 l)
and 500–1000 ml/day (1.5562.12 l) to those with a urinary
output greater than 1000 ml/day (1.2861.99 l) (one way
ANOVA: p,0.001), but with large interquartile range and
overlap. There was no correlation between ADTH and daily
ultrafiltration (R = 0.10), and only a weak correlation between
ADTH and estimated daily total fluid output (residual diuresis +
peritoneal ultrafiltration) (R = 0.17).
There was a negative relation between ADTH and serum
albumin (R =20.42), hemoglobin (R =20.34) and hematocrit
(R =20.31). There was no correlation between ADTH and
glomerular filtration rate or CRP-level.
There was a difference in ADTH in the univariate analysis
between patients using or not using polyglucose (0.962 vs 1.462 l
resp, p = 0.04) in the countries without logistical impediment to the
use of polyglucose. The relation between hydration status and use
of polyglucose was complex, with more patients being over-
hydrated in the group using polyglucose in Belgium, whereas in
UK and France, patients using polyglucose were less overhydrated
(table 2). In countries where the use of polyglucose was restricted
(Romania and Poland), the few patients using polyglucose tended
Fluid Status in PD by BCM
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to be more overhydrated (table 2), potentially indicating a bias by
indication.
There was a small difference in ADTH in univariate analysis
between patients on CAPD vs APD (1.362.0 vs 0.961.9 l resp,
p = 0.06) in these countries without logistical impediment to the
use of APD (Belgium, France, UK).
Multivariate analysis of tissue hydration
Because of the strong interaction, the multivariate analysis
included only patients from countries with unrestricted access to
APD and alternative PD solutions.
In this multivariable linear regression analysis adjusted for
country effects (table 3), older age, male gender, lower serum
albumin, lower BMI, diabetes, higher systolic blood pressure, and
use of at least once per day highest hypertonic glucose were
associated with higher relative tissue hydration. Neither urinary
output nor ultrafiltration was retained in the model. The use of
alternative dialysis solutions (including polyglucose) did not
contribute to the model (total R2 of the model = 0.57).
Discussion
The EuroBCM study is the first large multi-centre study of
hydration status and its associated factors in PD patients in Europe
allowing comparison to a healthy reference population. Fluid
overload was a frequent finding in PD patients as compared to a
Table 1. Demographic, clinical and fluid status data of the EuroBCM study cohort (N = 639).
mean or percentage Standard deviation
Gender Male 55%
Age (years) 58.8 14.8
Height (cm) 165.7 9.6
Weight (kg) 72.2 15.4
Body Mass Index (kg/m2) 26.3 5.1
Blood pressure (mmHg)
Systolic
Diastolic
136.9
79.9
25.6
14.3
Residual GFR (ml/min) 6.6 7.2
Ultrafiltration (ml/day) 940 580
Residual urine output
,100 ml/day
100–500 ml/day
500–1000 ml/day
.1000 ml/day
Missing data
19.1%
21.9%
23.5%
32.6%
3.0%
Treatment modality Automated PD1 53.1%
Use of polyglucose1 63.7%
Transport status
Fast
Fast average
Slow average
Slow
Not known
16.6%
33.3%
28.3%
5.9%
15.9%
Serum levels
Albumin (g/l)
Creatinine (mg/dl)
Urea (mg/dl)
C-reactiveprotein (mg/l)
Hemoglobin (g/dl)
Hematocrit (%)
HbA1C (%)
36.3
8.1
117.0
11.6
11.3
34.3
6.5
6.0
3.0
39.7
23.5
1.6
5.1
1.7
Absolute DTissue Hydration (ADTH) (l) 1.7
Q25: 0.2; Median 1.3; Q75: 2.9
2.3
Relative DTissue Hydration (%) (Ratio ADTH/ECW) 8.6
Q25: 1.1; Median 7.8; Q75: 15.1
11.5
Total Body Water (l) 35.8 7.7
Extracellular Water (l) 17.2 3.8
Intracellular water (l) 18.5 4.5
Extracellular/Intracellular water 0.95 0.15
Intracellular resistance Ri (Ohm/m) 569.6 117.5
Extracellular resistance Re (Ohm/m) 1611.6 479.5
Phase angle at 50 kHz 4.9 1.2
1after exclusion of patients from countries where polyglucose and APD are not liberally available due to logistical reasons.
doi:10.1371/journal.pone.0017148.t001
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Figure 1. Scatter plot of the relation between absolute Dtissue hydration (litres) in the X-axis and systolic blood pressure (mmHg)
in the Y-axis in the individual patients of the EuroBCM study cohort. Dotted vertical lines indicate the 10th and 90th percentile of absolute
Dtissue hydration in the healthy population (21.1 and +1.1 liter respectively), representing thus the limits of ‘‘normohydration’’. Dotted horizontal
lines indicate the ‘‘normotensive range’’ for systolic blood pressure.
doi:10.1371/journal.pone.0017148.g001
Figure 2. Box and whisker plots (median, 25th and 75th quartile, outliers) of Absolute DTissue Hydration (in liters) in the different
transport categories. n.d.: no peritoneal transport characteristics available in the 4 months before the BCM measurement.
doi:10.1371/journal.pone.0017148.g002
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healthy reference population [29], but comparable to that
reported in HD patients [20,22,23]. The deviation from the
relation between blood pressure and tissue hydration was
substantial, pointing out that blood pressure is not a good tool
to evaluate hydration status in PD patients. Overhydration was
associated with higher age, male gender, diabetes, lower BMI,
higher systolic blood pressure, and use of hypertonic solutions, and
in these conditions, physicians should have enhanced awareness
for volume status. Use of polyglucose or biocompatible glucose
solutions or the type of PD modality was not independently
associated with hydration status.
In the large cohort of the EuroBCM in PD study, a substantial
portion of patients were fluid overloaded by more than 1.1 litre,
the 90th percentile of absolute Dtissue hydration in the normal
Table 2. Tissue hydration related to percentiles of the normal reference population stratified for the use of polyglucose or not.
% ,10th percentile
of normal population
% between 10th and 90th percentile
of normal population
% .90th percentile
of normal population
Belgium
Polyglucose (n = 59)
No polyglucose (n = 39)
6.8
5.1
42.4
56.4
50.8
38.5
France
Polyglucose (n = 44)
No polyglucose (n = 21)
9.1
4.8
54.5
33.3
36.4
61.9
United Kingdom
Polyglucose (n = 113)
No polyglucose (n = 54)
16.8
9.3
47.8
38.9
35.4
51.8
Switzerland
Polyglucose (n = 7)
No polyglucose (n = 2)
0.0
0.0
0.0
50.0
100.0
50.0
Romania
Polyglucose (n = 17)
No polyglucose (n = 203)
1.0
2.8
33.0
35.3
66.0
60.0
Poland
Polyglucose(n = 9)
No polyglucose (n = 73)
4.1
11.1
35.6
44.4
60.3
44.4
doi:10.1371/journal.pone.0017148.t002
Table 3. Multivariate linear regression for Relative DTissue Hydration from the subgroup of patients from Belgium, France and UK.
Parameter Coefficient 95% CI p-value
Intercept 30.27 20.65 39.88 ,0.0001
Age (per year) 0.10 0.05 0,16 0.0002
Sex (female vs male) 23.04 24.55 21.52 0.0001
Albumin per g/l 20.75 20.91 20.59 ,0.0001
BMI per kg/m2 20.66 20.83 20.50 ,0.0001
Diabetes (vs no diabetes) 4.86 3.14 6.59 ,0.0001
Systolic BP (per mmHg) 0.09 0.05 0.12 ,0.0001
Glucose at least once 2.5% vs. 1.5% only 20.73 22.56 1.11 0.80
Glucose at least once 3.86/4.25% vs. 1.5% only 5.18 2.62 7.74 ,0.0001
Not included due to p.0.1
Ultrafiltration 0.86
Urine output 0.66
Hypertension stage 0.41
NYHA Stage 0.39
Liver disease 0.56
Time on PD per month 0.25
Transport status 0.83
Type of PD solution 0.12
PD modality 0.27
Model adjusted for country effects (Belgium, France and UK), total R2 of the model = 0.57, n = 299.
NYHA=New York Heart Association classification of heart failure.
doi:10.1371/journal.pone.0017148.t003
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reference population [29], and 25% of patients had a relativeD
tissue hydration/extracellular water ratio above 15%, a value
associated with increased mortality in HD patients [20].
Substantial fluid overload is therefore indeed a prevalent problem
in PD patients, and more attention should be given to its
assessment and correction. Nevertheless, it is important to note
that comparable numbers of severe fluid overload have been
reported in HD patients [20,22,23,24], and already in early stages
of renal impairment, patients tend to be more fluid overloaded
[40,41].
Many physicians estimate hydration status by using clinical
parameters, such as edema, weight gain or blood pressure[42].
Although there was a direct correlation between systolic blood
pressure and tissue hydration, a substantial proportion of patients
did not comply with this paradigm. A number of patients had
systolic hypertension, despite normohydration or even tissue
underhydration. These are probably patients who suffer from
vascular stiffness [2]. Further dehydration of these patients in an
attempt to normalize blood pressure might be dangerous, as it
might abruptly compromise coronary perfusion [43]. A number of
patients had a low or normal blood pressure, despite being fluid
overloaded. It is conceivable that many of these patients suffer
congestive heart failure. Normotension in these patients should not
be seen as equivalent to euvolemia, as also reported in HD patients
[22].
In many studies on fluid overload, attention is focused on fluid
output (ultrafiltration and/or diuresis), neglecting that fluid status
is a balance of fluid output and input. In the EuroBCM study,
there was a very weak association between fluid overload and
diuresis, but this association disappeared in the multivariate
analysis. Davison et al [25] found a small influence of residual
GFR, but not of peritoneal ultrafiltration or daily urine output, on
volume status. Wiggins et al [44] demonstrated that total fluid
output one month after the initiation of PD was not associated
with patient survival. All these point out that in studies on fluid
status, both fluid input and output should be considered. In
addition, and maybe even more of importance, clinicians should
be aware that patients can be overhydrated because of dietary
incompliance, despite having substantial residual diuresis. Dietary
intake of fluid and salt should thus be conisdered when managing
fluid overloaded patients.
In our BCM cohort, the use of high hypertonic bags was
associated with fluid overload. It is tempting to attribute this
observation to bias by indication. However, an alternative
potential hypothesis could be that the strategy of using hypertonic
bags is not effective in returning patients back to euvolemia for a
sustained period of time, as it can lead to dysregulation of glycemic
control, and thus to hyperosmolarity and thirst. Sustained
exposure to hypertonic exchanges can also negatively impact on
the peritoneal membrane function [45], leading to further
detrimental consequences on fluid balance. Further studies in this
regard are warranted. This is compatible with the negative impact
of high initial peritoneal fluid removal [44]: it is likely that those
with a high fluid output achieved this at the expense of increased
use of hypertonic bags, thus damaging the peritoneal membrane in
the long term.
There was an association between peritoneal membrane
transport characteristics and tissue hydration, as already demon-
strated by others [27]. Nevertheless, there was a substantial
overlap between groups, and the effect was rather small and
disappeared in the multivariate analysis. In the study by Davison
et al [25], transport status explained only 1.6% of the variation in
volume status. It can be hypothesized that fluid overload is
induced by not adapting the dwell time appropriately to the
transport status of the patient [46]. Although it has been stated
that removal of salt can be impaired in patients on APD [47],
hydration status in patients on APD and CAPD was comparable
in the multivariate analysis in the EuroBCM cohort, just as in
previous observations [25,26]. Of note, in one of these studies
[25], the number of cycles per night was limited, so the dwell time
was probably long enough to allow diffusive sodium transport. To
maintain fluid balance, fast transporters need short dwells, to avoid
negative ultrafiltration, and implementing APD might be of value
in this patient category. On the other hand, slow transporters need
long dwells to avoid sodium sieving, and APD with short cycles
might be detrimental in this patient group. Johnson et al [48]
recently reported that APD was associated with better survival in
fast, but with worse survival in low transporters, an observation
that is compatible with this paradigm.
As Davison et al (23), we found a negative association between
serum albumin and overhydration. As this is a cross-sectional
cohort, it is however impossible to determine whether low albumin
is a consequence or a cause of overhydration.
In the EuroBCM study cohort, polyglucose use was associated
with less overhydration and more underhydration in some
countries, whereas the opposite was true in other countries,
pointing to potential underlying differences in practice related to
the use of polyglucose (table 2). In a subcohort of the EuroBCM
trial, excluding countries were alternative PD solutions and APD
are not liberally available due to logistical reasons, we observed a
neutral impact both of the solution type and the PD modality on
fluid overload, just as it was found in the cohort of Davison et al
[25].
This study is a cross sectional study, and as such, no causal
relations can be drawn. However, our observations can generate
some interesting hypotheses on the association between practices
and hydration status. It would be interesting e.g. to study the
impact on hydration status and residual renal function using a
prospective protocol where implementation of polyglucose, dwell
length and use of APD vs CAPD is guided by BCM based
assessment of fluid overload. Another limitation is the rather crude
evaluation of fluid output using patient charts as a reference,
which might induce inaccuracies. However, this is the way fluid
output is measured in real life. Of special interest for a future
prospective study in this regard is the potential impact of bag
overfill on the overestimation of ultrafiltration and fluid overload
[49]. It can be that the overestimation of real ultrafiltration by
neglecting overfill can lead to overhydration, as it gives the patient
and the physician the false feeling of adequate ultrafiltration.
In conclusion, the EuroBCM study demonstrates some
interesting issues on volume status in PD patients: fluid overload
is a frequent problem, and relying only on clinical parameters for
its assessment might be misleading. Fluid overload is related to
prescription practices, gender and diabetes. Despite good
ultrafiltration and residual diuresis, patients still can be fluid
overloaded, stressing the important role of dietary restriction of
salt and fluid intake. Although indication bias cannot be excluded,
attempts to increase ultrafiltration by the long term use of
hypertonic bags [46] seem to be no guarantee for achieving
sustained euvolemia. Objective measurement of fluid status as a
basis for an integrated approach to fluid balance is warranted. As
fluid overload has been linked to mortality [7,20], further studies
evaluating whether awareness of hydration status can improve
volume management and patient outcome are warranted.
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